arrow
Y

Yukihiro Hamada

kochi medical school hospital
H指数:22
被引数:1,964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison between days of antibiotic spectrum coverage and days of therapy as risk factors for Clostridioides difficile infection: a multicenter retrospective cohort study

比较抗菌谱覆盖天数与治疗天数作为艰难梭菌感染风险因素的差异:一项多中心回顾性队列研究

2026-10-290
OA
Comparison of area under the concentration-time curve estimations between Practical Antimicrobial Therapeutic Drug Monitoring (PAT) versions 3 and 4 for vancomycin using two-point sampling

通过两点采样比较万古霉素实用抗菌治疗药物监测(PAT)第3版和第4版浓度-时间曲线下面积估算值

2026-07-010
PRE
Development of a risk prediction model for vancomycin-associated acute kidney injury: a multicentre retrospective study

万古霉素相关急性肾损伤风险预测模型的开发:一项多中心回顾性研究

2026-03-010
PRE
Optimization of cefepime dosage regimens for Pseudomonas aeruginosa infections in Japanese patients based on a pharmacokinetic/ pharmacodynamic analysis considering efficacy and safety: Is a 6 g daily dose and continuous infusion necessary?

基于药代动力学/药效学分析,考虑疗效与安全性,针对日本患者铜绿假单胞菌感染优化头孢吡肟给药方案:每日6克剂量和持续输注是否必要?

2025-12-010
PRE
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring

评估两点采样法在随访治疗药物监测中测定万古霉素曲线下面积的必要性

2025-10-010
PRE
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients
2025-10-010
PRE
Pharmacokinetics-Pharmacodynamics-Based Repositioning of Cefmetazole and Flomoxef in Extended-Spectrum β-Lactamase-Producing Enterobacterales Treatment: An Injectable Carbapenem-Sparing and Outpatient Strategy

基于药代动力学-药效学的cefmetazole和flomoxef在产广谱β-内酰胺酶肠杆菌科细菌感染治疗中的重定位:一种注射用碳青霉烯类节约且适用于门诊的策略

2025-08-260
PRE
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study

万古霉素治疗低血清肌酐水平患者AUC向上偏离的风险分层:一项多中心回顾性研究

2025-06-010
PRE
Reply to Mitsuboshi, Enhancing result reliability by addressing potential confounding factors

回复Mitsuboshi,通过解决潜在的混杂因素来提高结果的可靠性

2025-02-060
OAAI
Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan

合并便秘对心力衰竭患者生存的影响:一项在日本进行的、多中心前瞻性队列研究

2025-01-140
OA
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation
2024-10-212
PRE
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study
2024-07-026
OAAI